Tachyarrhythmias and neurologic complications

Catherine E Hassett; Sung-Min Cho; Jose I Suarez

doi:10.1016/B978-0-12-819814-8.00004-4

Tachyarrhythmias and neurologic complications

Handb Clin Neurol. 2021:177:151-162. doi: 10.1016/B978-0-12-819814-8.00004-4.

Authors

Catherine E Hassett¹, Sung-Min Cho², Jose I Suarez³

Affiliations

¹ Cerebrovascular Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States.
² Neurosciences Critical Care, Departments of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
³ Neurosciences Critical Care, Departments of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: jsuarez5@jhmi.edu.

PMID: 33632434
DOI: 10.1016/B978-0-12-819814-8.00004-4

Abstract

Tachyarrhythmias are abnormal heart rhythms with a ventricular rate of 100 or more beats per minute. These rhythms are classified as either narrow or wide-complex tachycardia with further subdivision into regular or irregular rhythm. Patients are frequently symptomatic presenting with palpitations, diaphoresis, dyspnea, chest pain, dizziness, and syncope. Sudden cardiac death may occur with certain arrhythmias. Recognizing tachyarrhythmia and understanding its management is important as a wide spectrum of neurologic complications have been associated with such arrhythmias. The purpose of this chapter is to provide a comprehensive overview on the neurologic complications of tachyarrhythmias, neurologic adverse events of antiarrhythmic interventions, and neurologic conditions that can precipitate tachyarrhythmia.

Keywords: Antiarrhythmic agents; Neurologic complications; Seizure; Stroke; Tachyarrhythmia; Tachycardia.

MeSH terms

Anti-Arrhythmia Agents / therapeutic use
Dizziness
Humans
Tachycardia* / drug therapy

Substances

Anti-Arrhythmia Agents